Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] …
Month: August 2024
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
SPONSORED CONTENT
On June 18th, RxParadigm hosted a webinar to discuss the pressing need for a 340B clearinghouse. Legislative changes at both state and federal levels for the 340B program could be imminent, requiring all stakeholders to adapt to new standards
…
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...] …
340B INDUSTRY LEADER SPOTLIGHT
Christina Breckenridge, Senior Director of Client Success, RxStrategies
Q: Where did you grow up?
Kansas City, Missouri
Q: Where did you go to college/graduate school?
For undergraduate work, I went to school in Springfield, Missouri, at what was then Southwest Missouri State University and is now Missouri State University. I earned 2 graduate degrees in Kansas City, Missouri, at the University of Missouri-Kansas City.
Q:
…
Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...] …
Missouri’s new law prohibiting drugmaker 340B contract pharmacy restrictions takes effect tomorrow, and the drug industry has responded with more [...] …
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...] …
If things were not difficult enough already for 340B providers, hospitals woke up on Friday morning to an announcement that [...] …